Non-Hematologic Toxicity of Bortezomib in Multiple Myeloma: The Neuromuscular and Cardiovascular Adverse Effects

SIMPLE SUMMARY: Multiple myeloma (MM) is a still uncurable tumor of mainly elderly patients originating from the terminally differentiated B cells. Introduction to the treatment of MM patients of a new class of drugs called proteasome inhibitors (bortezomib followed by carfilzomib and ixazomib) sign...

Descripción completa

Detalles Bibliográficos
Autores principales: Pancheri, Elia, Guglielmi, Valeria, Wilczynski, Grzegorz M., Malatesta, Manuela, Tonin, Paola, Tomelleri, Giuliano, Nowis, Dominika, Vattemi, Gaetano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563977/
https://www.ncbi.nlm.nih.gov/pubmed/32906684
http://dx.doi.org/10.3390/cancers12092540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563977/
https://www.ncbi.nlm.nih.gov/pubmed/32906684
http://dx.doi.org/10.3390/cancers12092540

Ejemplares similares